Q: What are the Open Access Journals are available in your Publishing group?
Ans: Please visit the mentioned link www.mathewsopenaccess.com to view the list of Journals that are available with us.
Q: How am I to submit my paper?
The candidate is required to send the paper to the individual email of each journal by visiting the concerned journal home page.
Q: When will my paper be published?
Ans: We publish the paper within 3 days after acceptance of the paper.
Q: How do I become peer-Reviewer to the Journal?
Q: Do Editor have to work continuously?
Ans: No, the editorial office will be helping you whenever required as we understand that you may be busy in other commitments.
Q: Whom do I have to contact at the Editorial office if I have any queries?
Q: What is the eligibility do I need to review a manuscript?
Ans: The reviewers are assigned by the Editors as per the research matching to the topic field of manuscript. Self registered peer reviewers must be having a few published papers in the field of interest they mentioned.
Q: Where do I have to submit the Review comments?
Ans: Please submit your review comments in the mentioned form and send us to respective email ID from which you have had received the Manuscript to review.
Q: Is there any limit to review papers?
Ans: No. You may review as many manuscripts you wish according to manuscript topic match your interest.
Published : 25th September 2019
Authors : Olorunfemi Stephen
Citation : Stephen O. (2019). HIV Drugs Resistance - A Possible Consequence of Massive Anti-Retroviral Roll Out in Developing Countries - an Urgent Call For 1
Proper Monitoring (Part 1). Mathews J HIV AIDS 4(1): 20.
Published : 12th November 2018
Authors : Paulo Pereira1*, Sandra Xavier2
Citation : Pereira P and Xavier S. (2018). Computation of the Diagnostic Uncertainty as an Alternative to the Determination of Measurement Uncertainty for HIV Qualitative Binary Results. Mathews J HIV AIDS 3(1): 019
Published : 23rd July 2018
Authors : Berry Ikolango Bongenya1*, Ramazani Nemwanjare Bukongo1 , Ben Ilunga Bulanda1, Divine chuga1, Jean Yves Debels Kabasele1, Medard Omakoy Okonda1, Christian Tshisumbu1, Erick Ntambwe kamangu*1,2
Citation : Kamangu EN, Bongenya BI, Bukongo RN, Bulanda BI, et al. (2018). Gender Difference in Early Treatment Patients for Human Immunodeficiency Virus Type 1 Infection in Kinshasa, Democratic Republic of Congo.Mathews J HIV AIDS. 3(1): 018
Published : 05th January 2018
Authors : Callist L. Chomboko1*, Rogatus M. Kabyemera2 , Benson R. Kidenya3, Erasmus Kamugisha 3*
Citation : Kamugisha E, Chomboko CL, Kabyemera RM, and Kidenya BR. (2018). Prevalence and Predictors of Immunological Treatment Failure among HIV Infected Adults on the First-line Antiretroviral Therapy in Mbeya Region, Tanzania. Mathews J HIV AIDS. 3(1): 017
Published : 08th December 2017
Authors : Erasmus Kamugisha1 *, Jeremiah Kidola2 , Stephen E. Mshana3
Citation : Kamugisha E, Kidola J and Mshana SE. (2017). HIV p24 Antigen Assay in the Diagnosis of Immunological Failure Among Patients with HIV Infection in Mwanza City. Mathews J HIV AIDS. 2(1): 016
Published : 04th December 2017
Author : Paulo Pereira
Citation : Pereira P. (2016). Editor Note. Mathews J HIV AIDS. 2(1): 012.
Published : 03rd March 2017
Author : Paulo Pereira
Citation : Pereira P. (2017). Computation of the "Gray Zone" based on experimental data and its effect on the trueness in HIV results in the blood, cells, and tissues banks. Mathews J HIV AIDS. 2(1): 015
Published : 20th February 2017
Authors : Erick Ntambwe Kamangu1, 2*, Berry Bongenia Ikolango2, Ben Bulanda Ilunga2
Citation : Kamangu EN, Ikolango BB and Ilunga BB. (2017). Evolution of Subtypes of the Human Immunodeficiency Virus Type 1 in Kinshasa over the Last 30 years: Documentary Review from 1985 to 2015. Mathews J HIV AIDS. 2(1): 014.
Published : 15th February 2017
Authors : Siva Narayanan*, Joseph Black
Citation : Narayanan S and Black J. (2017). The Case for Greater Access for Once-Daily Single Tablet Regimens to Treat HIV Infection in Europe. Mathews J HIV AIDS. 2(1): 013.